Teva Gets a Two-For - Motley Fool
Teva Gets a Two-ForMotley Fool - 4 hours agoYesterday, Teva announced the second consecutive FDA approval, this time for a generic version of Pfizer's (NYSE: PFE) hypertension treatment Accupril. …Cardiome's Hearty Outlook Motley Foolall 2 news articles
Read full story